ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

ClinicalTrials.gov ID: NCT03185013

Public ClinicalTrials.gov record NCT03185013. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix

Study identification

NCT ID
NCT03185013
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Inovio Pharmaceuticals
Industry
Enrollment
201 participants

Conditions and interventions

Interventions

  • Electroporation (EP) Device
  • Placebo Biological
  • VGX-3100 Biological

Device · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 27, 2017
Primary completion
Jul 7, 2020
Completion
Apr 5, 2021
Last update posted
Jul 26, 2023

2017 – 2021

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Mesa Obstetricians and Gynecologist Mesa Arizona 85209
Women's Health Research Scottsdale Arizona 85251
Visions Clinical Research-Tucson Tucson Arizona 85712
Women's Medical Research Group Clearwater Florida 33759
Altus Research Lake Worth Florida 33461
Salom and Tangir LLC Miramar Florida 33461
Comprehensive Clinical Trials LLC West Palm Beach Florida 33409
Augusta University Augusta Georgia 30912
Praetorian Pharmaceutical Research, LLC Marrero Louisiana 70072
Saginaw Valley Medical Research Group LLC Saginaw Michigan 48604
Meridian Clinical Research Norfolk Norfolk Nebraska 68701
New Jersey Medical School Newark New Jersey 07103
Columbia University Medical Center New York New York 10032
Suffolk Obstetrics and Gynecology Port Jefferson New York 11777
Lyndhurst Clinical Research Winston-Salem North Carolina 27103
Greenville Pharmaceutical Research, Inc. Greenville South Carolina 29615
Magnolia Ob/Gyn Research Center, LLC Myrtle Beach South Carolina 29572
Chattanooga Medical Research Inc Chattanooga Tennessee 37404
Women's Physician Group Memphis Tennessee 38104
UAG Innovation Women Research, LLC Houston Texas 77074
Group For Women Norfolk Virginia 23502
Eastern Virginia Medical School Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03185013, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2023 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03185013 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →